← Leaderboards
Angela Haczku
University Of Pennsylvania
$7,604,827
Attributed
$9,445,870
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$9,445,870 · 9
By mechanism
R01$4,007,877 · 3
R42$2,964,295 · 1
R21$1,195,906 · 3
RC1$1,000,000 · 1
R41$277,792 · 1
Top collaborators
- Thais Motria Sielecki4 shared
- Martha S Jordan2 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Melpo Christofidou-Solomidou$5,805,617
- Kelly L Jordan-Sciutto$26,892,677
- Taewan John Kim$483,826
- Philippe O Szapary$2,140,747
- Robert M Lavker$20,902,357
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
Research focus
AsthmaCellsRegulationInflammationAirway InflammationAllergensResponseIn VivoMolecularInflammatoryDendritic CellsImmunePathway InteractionsProductionPredispositionNf-Kappa BCell TypePreventIn VitroEpithelial CellsLungMediatingPulmonary Surfactant-Associated Protein DStress
Grant awards (23)
IND enabling development of LGM2605 as adjuvant treatment for asthma$964,295
R42 · FY2021 · AI
IND enabling development of LGM2605 as adjuvant treatment for asthma$1,000,000
R42 · FY2020 · AI
IND enabling development of LGM2605 as adjuvant treatment for asthma$1,000,000
R42 · FY2019 · AI
Effects of LGM2605 on a Primate Model of Asthma$277,792
R41 · FY2017 · AI
Asthma, anxiety and GR abnormalities in non-human primates$236,761
R21 · FY2016 · AI · contact PI
Asthma, anxiety and GR abnormalities in non-human primates$210,920
R21 · FY2015 · AI · contact PI
Mechanisms of social-stress enhanced allergic airway response in a mouse model$395,908
R01 · FY2014 · AI · contact PI
Natural Th17 cells in allergic airway disease$240,000
R21 · FY2014 · AI
Mechanisms of social-stress enhanced allergic airway response in a mouse model$372,518
R01 · FY2013 · AI · contact PI
Natural Th17 cells in allergic airway disease$200,000
R21 · FY2013 · AI
Mechanisms of social-stress enhanced allergic airway response in a mouse model$399,092
R01 · FY2012 · AI · contact PI
Mechanisms of social-stress enhanced allergic airway response in a mouse model$402,390
R01 · FY2011 · AI · contact PI
Effects of ozone exposure on expression and function of surfactant protein D$500,000
RC1 · FY2010 · ES · contact PI
Mechanisms of social-stress enhanced allergic airway response in a mouse model$406,054
R01 · FY2010 · AI · contact PI
Effects of ozone exposure on expression and function of surfactant protein D$500,000
RC1 · FY2009 · ES · contact PI
Regulation of Inflammation in Asthma by Fas Ligand$354,530
R01 · FY2009 · HL · contact PI
Surfactant-Protein Innate Immunity in an Asthma Model$331,721
R01 · FY2008 · AI · contact PI
Regulation of Inflammation in Asthma by Fas Ligand$89,482
R01 · FY2008 · HL · contact PI
Surfactant-Protein Innate Immunity in an Asthma Model$338,145
R01 · FY2007 · AI · contact PI
Surfactant-Protein Innate Immunity in an Asthma Model$348,245
R01 · FY2006 · AI · contact PI
Surfactant-Protein Innate Immunity in an Asthma Model$350,775
R01 · FY2005 · AI
Surfactant-Protein Innate Immunity in an Asthma Model$219,017
R01 · FY2004 · AI
Surfactant-Protein Innate Immunity in an Asthma Model$308,225
R21 · FY2003 · AI